(Q33730692)

29 July 2017

1 reference

title

Assessing "best evidence": issues in grading the quality of studies for systematic reviews (English)

1 reference

29 July 2017

1 reference

K N Lohr

1

1 reference

29 July 2017

T S Carey

series ordinal

2

1 reference

29 July 2017

publication date

1 September 1999

1 reference

The Joint Commission journal on quality improvement

29 July 2017

published in

1 reference

29 July 2017

volume

25

1 reference

29 July 2017

issue

9

1 reference

29 July 2017

page(s)

470-479

1 reference

Evidence-based medicine. A new approach to teaching the practice of medicine

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930461-8

7 January 2021

Users' guides to the medical literature

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930461-8

7 January 2021

Health policy issues and applications for evidence-based medicine and clinical practice guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930461-8

7 January 2021

Validation of an index of the quality of review articles

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930461-8

7 January 2021

Instruments for assessing the quality of drug studies published in the medical literature

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930461-8

7 January 2021

Rating the quality of evidence for clinical practice guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930461-8

7 January 2021

A method for assessing the quality of a randomized control trial

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930461-8

7 January 2021

Bias in treatment assignment in controlled clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930461-8

7 January 2021

How study design affects outcomes in comparisons of therapy. I: Medical

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930461-8

7 January 2021

How study design affects outcomes in comparisons of therapy. II: Surgical.

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930461-8

7 January 2021

An empirical study of the possible relation of treatment differences to quality scores in controlled randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930461-8

7 January 2021

Incorporating variations in the quality of individual randomized trials into meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930461-8

7 January 2021

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930461-8

7 January 2021

Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930461-8

7 January 2021

Assessing the quality of randomized controlled trials. Current issues and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930461-8

7 January 2021

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930461-8

7 January 2021

Does blinding of readers affect the results of meta-analyses? University of Pennsylvania Meta-analysis Blinding Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930461-8

7 January 2021

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930461-8

7 January 2021

Cost-Effectiveness of Implantable Cardioverter Defibrillators Relative to Amiodarone for Prevention of Sudden Cardiac Death

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930461-8

7 January 2021

Pharmacological treatment of alcohol dependence: a review of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930461-8

7 January 2021

The effects of blinding on the quality of peer review. A randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930461-8

7 January 2021

Effect of blinding and unmasking on the quality of peer review: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930461-8

7 January 2021

Effect on the Quality of Peer Review of Blinding Reviewers and Asking Them to Sign Their Reports

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930461-8

7 January 2021

Does masking author identity improve peer review quality? A randomized controlled trial. PEER Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930461-8

7 January 2021

Alcoholism treatment outcome studies, 1980-1992: methodological characteristics and quality

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930461-8

7 January 2021

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930461-8

7 January 2021

Beyond CONSORT: need for improved reporting standards for clinical trials. Consolidated Standards of Reporting Trials

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930461-8

7 January 2021

CONSORT: An Evolving Tool to Help Improve the Quality of Reports of Randomized Controlled Trials

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930461-8

7 January 2021

10.1016/S1070-3241(16)30461-8

Identifiers

DOI

1 reference

29 July 2017

1 reference